← Leaderboards
Zufeng Ding
Univ Of Arkansas For Med Scis
$1,804,000
Attributed
$1,804,000
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $570K · FY2022–25$1M$750K$500K$250K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$1,804,000 · 2
By mechanism
R01$1,386,000 · 1
R21$418,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Binding”
- Xuping Xie · University Of Texas Med Br Galveston$13,737,799
- Heinz Ernst Moser · University Of Texas Med Br Galveston$12,973,432
- Jason Dickens · Duke University$12,259,409
- Colin Osborne · University Of Texas Med Br Galveston$10,407,745
- Jeff T Hutchins · Inhalon Biopharma, Inc.$9,139,075
- Joseph Fraser Glickman · Hackensack University Medical Center$8,363,749
Research focus
BindingVascular Endothelial CellApoptoticKnock-OutPhagocytesPreventDrug DesignEventImpairmentInnovationMediatingPathogenesisPlayBlood VesselsAffectCardiovascular SystemEndotheliumEndothelial CellsAortic ArchCessation Of LifeCellsAortaLow Density Lipoprotein ReceptorArterial Fatty Streak
Grant awards (6)
Impact of hemodynamics on efferocytosis in endothelial cells$351,000
R01 · FY2025 · HL · contact PI
Impact of hemodynamics on efferocytosis in endothelial cells$351,000
R01 · FY2024 · HL · contact PI
Impact of hemodynamics on efferocytosis in endothelial cells$342,000
R01 · FY2023 · HL · contact PI
Mechanisms of PCSK9 in endothelial aging$190,000
R21 · FY2023 · AG · contact PI
Impact of hemodynamics on efferocytosis in endothelial cells$342,000
R01 · FY2022 · HL · contact PI
Mechanisms of PCSK9 in endothelial aging$228,000
R21 · FY2022 · AG · contact PI